Noxopharm Ltd
Price Chart
OHLC · volume · moving averages
Market Statistics
Today's trading range
Valuation
Fundamental multiples
Trading Activity
Volume & order book
Performance
Returns across timeframes
Technical Indicators
Momentum & moving averages
— From the desk
Latest News
Noxopharm Advances HERACLES Trial as Sofra Platform Gains US Momentum
Noxopharm (ASX: NOX) has successfully completed the second dosing cohort in its first-in-human HERACLES trial for novel autoimmune drug candidate SOF-SKN. The safety steering committee confirmed the dose level was safe and tolerable, enabling the study to progress to a higher concentration in the next cohort. The company also reported promising preclinical results from a […]
Noxopharm advances Chroma drug platform to target glioblastoma and leukaemia
Noxopharm (ASX: NOX) has made ‘substantial progress’ with its Chroma technology platform, reporting encouraging brain cancer results and early work on leukaemia. The Chroma drug development program focuses on generating first-in-class novel cancer treatment options in areas of substantial unmet need to create future commercial opportunities for the company. Glioblastoma – a lethal and incurable […]
Noxopharm reports CRO-67 breakthrough in pancreatic cancer treatment
Australian biotech company Noxopharm (ASX: NOX) has announced encouraging new data regarding the development of its CRO-67 preclinical drug for pancreatic cancer. The results arise from a study that tested CRO-67 in a complex model of human pancreatic cancer cells and barrier cells transplanted into the pancreas of mice. The new data showed a significant […]
Market wrap: ASX 200 closes below 7000-point mark despite a tentative recovery
The Australian share market took a couple of tentative steps in the upwards direction after a tough week in which the ASX 200 fell decisively below the important 7000-point mark. By the Friday close the index had limped upwards 0.4% or 28.7 points to 6,954.2 points after two positive days which followed on from a […]